Children's Hospital of Fudan University
ding Q i Ang
To investigate the efficacy of EEG biofeedback and drug therapy in the treatment of tic disorders
Tic Disorders
Drug Aripiprazole
biofeedback
Phase 4
This study intends to investigate the efficacy of EEG biofeedback and drug therapy on clinical symptoms, cognitive flexibility and quality of life in chronic tic disorder and Tourette syndrome through a randomized controlled study.}}
Study Type : | Interventional |
Estimated Enrollment : | 40 participants |
Masking : | Double |
Primary Purpose : | Treatment |
Official Title : | Efficacy of Biofeedback in the Treatment of Tic Disorder:A Randomized Controlled Trial |
Actual Study Start Date : | June 1, 2024 |
Estimated Primary Completion Date : | December 31, 2026 |
Estimated Study Completion Date : | December 31, 2027 |
Arm | Intervention/treatment |
---|---|
Experimental: Biofeedback therapy three times a week, every other day interval, 30 minutes each time, each subject received 20 biofeedback training (using the Infiniti3000A biofeedback system Patients in the theta group decreased the theta amplitude at Cz. Patients in the theta group received positive feedback when their theta activity was below the feedback threshold. |
Device: biofeedback |
Active Comparator: Drug therapy Considering the patients with chronic tic disorder (chronic motor or vocal tic disorder or Tourette's disorder), aripiprazole was selected as a single drug with constant dose during the treatment. In case of extrapyramidal side effects, benhexol was given to reduce the extrapyramidal side effects, and the dosage and duration of medication were recorded |
Drug: Drug Aripiprazole |
Ages Eligible for Study: | 8 Years to 16 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Children's hospital of Fudan University
Shanghai, Shanghai, China, 201102